IJCRR - 9(2), January, 2017
Amlodipine - A Novel Offender of Gingival Overgrowth-A Case Report
Author: Shobana P., Ramakrishnan T., Nirmala J. I., Vidya Sekhar, Manisunder N., Ebenezer M.
Aim: There are only few cases presented with Amlodipine-induced gingival enlargement so far. The main purpose of this case report is to discuss about Amlodipine-influenced gingival enlargement in a 56 years old female hypertensive patient and its periodontal management and maintenance. Case Report: In this case report, patient with a history of hypertension for past 2 years and presenting with Amlodipine-induced gingival enlargement and various approaches to manage it were discussed. Discussion: One of the common clinical features of gingival disease is gingival enlargement, otherwise termed as Gingival Overgrowth. Gingival enlargement occurs as a side effect following the administration of certain drugs. The most common drugs causing gingival enlargement are Anticonvulsants for eg Phenytoin, immuno-suppressants like Cyclosporine and calcium channel blockers (Nifedipine). Amlodipine - a third-generation calcium channel blocker is found to be associated with Gingival overgrowth even when prescribed in a very low dose of about 5mg. Conclusion: The results of this case report suggested that the combined non-surgical and surgical therapy resulted in complete healing of the gingival overgrowth with less post-operative complication.
Keywords: Drug-Induced Gingival Overgrowth (DIGO), Calcium Channel Blockers (CCBs), Gingivectomy and Amlodipine
Shobana P., Ramakrishnan T., Nirmala J. I., Vidya Sekhar, Manisunder N., Ebenezer M.. Amlodipine - A Novel Offender of Gingival Overgrowth-A Case Report International Journal of Current Research and Review. 9(2), January, 05-08
1. American Academy of Periodontology, editor. Glossary of periodontal terms. American Academy of Periodontology; 2001.4th ed:21
2. Joshi S, Bansal S. A rare case report of amlodipine-induced gingival enlargement and review of its pathogenesis. Case reports in dentistry. 2013 Aug 6;2013.
3. Srivastava AK, Kundu D, Bandyopadhyay P, Pal AK. Management of amlodipine-induced gingival enlargement: Series of three cases. Journal of Indian Society of Periodontology. 2010 Oct 1;14(4):279.
4. Tejnani A, Gandevivala A, Bhanushali D, Gourkhede S. Combined treatment for a combined enlargement. Journal of Indian Society of Periodontology. 2014 Jul;18(4):516.
5. Fardal Ø, Lygre H. Management of periodontal disease in patients using calcium channel blockers–gingival overgrowth, prescribed medications, treatment responses and added treatment costs. Journal of clinical periodontology. 2015 Jul 1;42(7):640- 6.
6. Newman MG, Takei H, Klokkevold PR, Carranza FA. Carranza’s clinical periodontology. Elsevier health sciences; 2011 Feb 14:118.
7. Bharti V, Bansal C. Drug-induced gingival overgrowth: the nemesis of gingiva unravelled. Journal of Indian Society of Periodontology. 2013 Mar 1;17(2):182.
8. Tripathi AK, Mukherjee S, Saimbi CS, Kumar V. Low dose amlodipine-induced gingival enlargement: A clinical case series. Contemporary clinical dentistry. 2015 Jan;6(1):107.